Company Profile

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE4418.257.25 (+0.16 % )
PREV CLOSE (Rs.) 4411.00
OPEN PRICE (Rs.) 4410.00
BID PRICE (QTY) 4418.25 (4 )
OFFER PRICE (QTY) 4425.00 (15 )
VOLUME 506
TODAY'S LOW / HIGH (Rs.)4391.75 4435.90
52 WK LOW / HIGH (Rs.)2927.8 4988
NSE4419.00 12.25 (+0.28 % )
PREV CLOSE(Rs.) 4406.75
OPEN PRICE (Rs.) 4400.00
BID PRICE (QTY) 4413.10 (8 )
OFFER PRICE (QTY) 4426.75 (8 )
VOLUME 7460
TODAY'S LOW / HIGH(Rs.) 4393.70 4437.05
52 WK LOW / HIGH (Rs.)2891.45 4988.65

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 9.96
TTM EPS (Rs.) 99.11
P/E Ratio 44.56
Book Value (Rs.) 520.07
Face Value (Rs.) 10
MCap (Rs. in Mn) 73305.36
Price/Earning (TTM) 40.37
Price/Sales (TTM) 7.94
Price/Book (MRQ) 8.49
PAT Margin (%) 98.79
ROCE (%) 100.08
Incorporation Year : 1967

Management Info :

Suresh N Talwar - Chairman Milind Thatte - Managing Director

Registered Office :

Address : Godrej One, 8th Floor,Pirojshanagar,Eastern Express Highway, Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone : 022 6210 9000

Website : www.merck.co.in

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
20Mar03-20-2020$Procter & Gamble Health informs about loss of share certificate Procter & Gamble Health info

Procter & Gamble Health has informed about the loss/ misplacement of the share certificate of Rupa D Patel (Folio No: R001754) as detailed in the attachment.

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has informed about the loss/ mispla..
17Mar03-17-2020$Procter & Gamble Health informs about voting results Procter & Gamble Health info

Procter & Gamble Health has informed that the Company enclosed voting results in respect of the Postal Ballot process, as required under Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015; and Scrutinizers Report.

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has informed that the Company enclo..
25Jan01-25-2020$Procter & Gamble Health informs about loss of share certificates Procter & Gamble Health info

Procter & Gamble Health has been informed by shareholder, Yogesh Babulal Shah about the loss /misplacement of the share certificate. 

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has been informed by shareholder, Y..
22Jan01-22-2020$Procter & Gamble Health informs about details of loss of share certificate Procter & Gamble Health info

Procter & Gamble Health has been informed by the shareholder, Somdatt Dhingra and Usha Dhingra about the loss/ misplacement of the share certificate.

The above information is a part of company’s filings submitted to BSE

Procter & Gamble Health has been informed by the shareholde..
14Jan01-14-2020$Procter & Gamble Health enters into partnership with PHFI Procter & Gamble Health ente

Procter & Gamble Health (P&G Health) has entered into partnership with the Public Health Foundation of India (PHFI) to implement a digital health project in the state of Goa under its corporate social responsibility (CSR) program ‘SEHAT’.

P&G Health (formerly Merck) operates both its pharmaceuticals and chemicals businesses in the country. Merck was also the first Merck Group Company to go public in the year 1981.

Procter & Gamble Health (P&G Health) has entered into p..
Financials More
Rs. in Millions
QTR Mar 20 ANNUAL 19
Net Profit464.621587.58
Gross Profit 647.64 2343.59
Operating Profit 690.022515.24
Net Sales 2281.069265.98
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Aarti Drugs (BSE)
 2064.00 (9.64%)
M.Cap ( in Cr)
4797.47
Valiant Organics (BSE)
 2334.00 (7.81%)
M.Cap ( in Cr)
2806.47
Torrent Pharma (BSE)
 2931.10 (2.47%)
M.Cap ( in Cr)
49595.08
Divis Lab (BSE)
 2728.15 (2.32%)
M.Cap ( in Cr)
72345.50
Caplin Point Lab (BSE)
 620.00 (8.14%)
M.Cap ( in Cr)
4631.23
Shareholding Pattern More
FI/BANKS/INSURANCE 6.19 %
PROMOTERS 51.82 %
MUTUAL FUNDS/UTI 4.7 %
NON-INSTITUTION 32.53 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes